PrimeGen

PrimeGen is a biotechnology company specializing in regenerative medicine and stem cell technologies. Founded in 2002, the company is a pioneer in the development of pluripotent stem cell therapies derived from adult tissues through its proprietary PrimeCell technology. This platform focuses on the isolation and reprogramming of adult germline stem cells, particularly from the testes, to create versatile therapeutic cells capable of differentiating into various tissue types. PrimeGen's research portfolio targets a wide range of conditions, including cardiovascular diseases, neurodegenerative disorders, and metabolic conditions, aiming to provide the benefits of embryonic stem cells without the associated ethical concerns. In addition to its therapeutic research, the company provides comprehensive stem cell banking services for umbilical cord blood, cord tissue, and adipose tissue, operating globally with a significant presence in the United States and Asia.